ARCHIVES

Nexavar Phase III Trial Fails To Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Research Advocates Prepare to Face Republican-led Congress

December 19, 2014

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

May 18, 2012

Chest X-Rays In BRCA Carriers May Increase Cancer Risk

July 28, 2006

Lombardi Center, Virgin Islands Collaborate On Patient Care

August 7, 1981

NCAB Subcommittee Approves Compromise On Changes In Organ Site Program

April 9, 1982

DRCCA Board Oks Noncompetitive Contract Concepts

November 11, 1983